Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Leipe

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Frontiers in Cardiovascular Medicine|July 12, 2023
High genetic risk for depression as an independent risk factor for mortality in patients referred for coronary angiographyRobert M Krämer, Angela P Moissl, Stefan Lorkowski, et al.
Rheumatology International|September 10, 2022
Comparison of physician and artificial intelligence-based symptom checker diagnostic accuracyMarkus Gräf, Johannes Knitza, Jan Leipe, et al.
Zeitschrift Fur Rheumatologie|January 4, 2023
[Immune-mediated inflammatory diseases in Germany : A cross-sectional analysis of comorbidities and pharmacotherapy]Jan Leipe, Renate Schmelz, Gabriela Riemekasten, et al.
The Lancet. Oncology|February 6, 2025
Management of immune checkpoint inhibitor-associated toxicities in older adults with cancer: recommendations from the International Society of Geriatric Oncology (SIOG)Colm Mac Eochagain, Nina Rosa Neuendorff, Karolina Gente, et al.
Zeitschrift Fur Rheumatologie|August 7, 2020
[Recommendations of the German Society for Rheumatology for management of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic - Update July 2020]Hendrik Schulze-Koops, Christof Iking-Konert, Jan Leipe, et al.
Rheumatology Advances in Practice|June 7, 2022
Experience with telemedicine among rheumatology clinicians during the COVID-19 pandemic: an international surveyEugenia Yupei Chock, Michael Putman, Richard Conway, et al.
Annals of the Rheumatic Diseases|December 26, 2025
Inflammation rather than anticitrullinated protein antibodies is associated with cardiovascular mortality in RA: insights from rheumatoid arthritis and coronary artery disease cohortsVeerle F A M Derksen, Jane Lindschou, Per Winkel, et al.
Zeitschrift Fur Rheumatologie|July 26, 2021
[Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV‑2/COVID‑19 pandemic, including recommendations for COVID‑19 vaccination]Christof Specker, Peer Aries, Jürgen Braun, et al.
Zeitschrift Fur Rheumatologie|September 7, 2021
Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic, including recommendations for COVID-19 vaccinationChristof Specker, Peer Aries, Jürgen Braun, et al.
Nature Aging|June 4, 2024
Cell type mapping of inflammatory muscle diseases highlights selective myofiber vulnerability in inclusion body myositisSven Wischnewski, Thomas Thäwel, Chiseko Ikenaga, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Frontiers in Cardiovascular Medicine|July 12, 2023
High genetic risk for depression as an independent risk factor for mortality in patients referred for coronary angiographyRobert M Krämer, Angela P Moissl, Stefan Lorkowski, et al.
Rheumatology International|September 10, 2022
Comparison of physician and artificial intelligence-based symptom checker diagnostic accuracyMarkus Gräf, Johannes Knitza, Jan Leipe, et al.
Zeitschrift Fur Rheumatologie|January 4, 2023
[Immune-mediated inflammatory diseases in Germany : A cross-sectional analysis of comorbidities and pharmacotherapy]Jan Leipe, Renate Schmelz, Gabriela Riemekasten, et al.
The Lancet. Oncology|February 6, 2025
Management of immune checkpoint inhibitor-associated toxicities in older adults with cancer: recommendations from the International Society of Geriatric Oncology (SIOG)Colm Mac Eochagain, Nina Rosa Neuendorff, Karolina Gente, et al.
Zeitschrift Fur Rheumatologie|August 7, 2020
[Recommendations of the German Society for Rheumatology for management of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic - Update July 2020]Hendrik Schulze-Koops, Christof Iking-Konert, Jan Leipe, et al.
Rheumatology Advances in Practice|June 7, 2022
Experience with telemedicine among rheumatology clinicians during the COVID-19 pandemic: an international surveyEugenia Yupei Chock, Michael Putman, Richard Conway, et al.
Annals of the Rheumatic Diseases|December 26, 2025
Inflammation rather than anticitrullinated protein antibodies is associated with cardiovascular mortality in RA: insights from rheumatoid arthritis and coronary artery disease cohortsVeerle F A M Derksen, Jane Lindschou, Per Winkel, et al.
Zeitschrift Fur Rheumatologie|July 26, 2021
[Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV‑2/COVID‑19 pandemic, including recommendations for COVID‑19 vaccination]Christof Specker, Peer Aries, Jürgen Braun, et al.
Zeitschrift Fur Rheumatologie|September 7, 2021
Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic, including recommendations for COVID-19 vaccinationChristof Specker, Peer Aries, Jürgen Braun, et al.
Nature Aging|June 4, 2024
Cell type mapping of inflammatory muscle diseases highlights selective myofiber vulnerability in inclusion body myositisSven Wischnewski, Thomas Thäwel, Chiseko Ikenaga, et al.
Pageof 9